Registry study for recent high-risk blood clot in the lungs
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial is a registry that collects information about people with a recent lung blood clot diagnosed by CT scan. It particularly focuses on higher-risk cases to better understand outcomes and care in the first 2 weeks after symptoms start.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your lung blood clot (pulmonary embolism) must be confirmed by a CT scan with contrast (CT pulmonary angiography).
- Your symptoms must have started 14 days or less ago.
- You must be in a higher-risk group, such as having very unstable circulation (cardiac arrest, shock, or ongoing low blood pressure).
- Alternatively, you may qualify if your heart’s right side is under strain (right ventricle dysfunction on imaging) and a blood test called troponin is elevated.
- You must be willing to sign the informed consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at repeated scans and tests for people who have had a pulmonary embolism (PE) — a blood clot in the lungs. It aims to improve how doctors monitor recovery and decide on treatment.
This study looks at whether a new way of grouping patients with blood clots in the lungs (pulmonary embolism) can better predict their outcomes. If you join, your health will be tracked for 30 days to see how well this new system works.
This trial looks at how people do after an acute pulmonary embolism (a blood clot in the lungs). It aims to understand real-world outcomes over follow-up and may help improve how care teams track patients after treatment.
This study compares different real-world treatments for a serious but stable type of blood clot in the lungs (called intermediate-high risk pulmonary embolism). It aims to see which treatments work best in everyday patients, including those with other health conditions.
This study follows people who have had a pulmonary embolism (a blood clot in the lungs) to understand their health over time and improve future care. It does not test a new treatment but collects information to learn more about recovery.
This study tests a new catheter-based device that delivers clot-dissolving medicine directly to the blood clot in the lungs for people with a moderate-risk pulmonary embolism. The goal is to improve blood flow to the lungs and relieve symptoms with a lower dose of medication than standard care.
Hear when a new Pulmonary Embolism With Acute Cor Pulmonale trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.